Clinical Characteristics Analysis of 9 Cases COVID-19 PatientsReceiving Integrated Traditional Chinese and Western Medicine:A Retrospective Study
DOI:
https://doi.org/10.47363/JTMCM/2024(2)110Keywords:
2019-nCoV, COVID-19, Chinese Medicine, Western Medicine, Complementary TherapyAbstract
Recently 2019-nCov is still spreading around the world, vaccines have been developed but still no specific medicine so far, so here we want to provide a potential and complementary plan to COVID-19 or even other epidemic diseases. So, we hypothesized Traditional Chinese Medicine (TCM) may have positive effect on cure of COVID-19. Here we report 9 COVID-19 patients hospitalized in our hospital, including 8 mild-type and 1 severe-type. Besides antiviral and other supportive treatment (Western Medicine, WM), all of them received Traditional Chinese Medicine (TCM) at the same time, and we collected the epidemiological, demographic, clinical and laboratory data of the patients and analyzed the outcome. After treatment by integration of WM and TCM, the pulmonary inflammations are gradually absorbed and finally disappeared, and other laboratory tests turned to normal (hs-CRP, T lymphocytes, CD4+ T cells and CD8+ T, etc.). All patients (including the severe type) have been discharged from the hospital, and the shortest course of treatment is only 12 days. Together with the fact that other parts of China using TCM, we speculate TCM might play an encouraging role in this process and may be an adjuvant and complementary therapy of COVID-19, combined with the application of defeating SARS, which may bring a meaningful reference to COVID-19 or even other epidemic diseases’ treatment worldwide, in spite of the efficacy and definite conclusions still need further study